Noveadent

Dental caries is the most prevalent disease in the world, with 2.3 billion people affected. It is therefore no surprise that dentists spend a large fraction of their time carrying out 'restorative treatments', where caried tissues are replaced with an inert material. Dentists feel current materials take too long to place and exhibit insufficient biocompatibility for their patients.

Noveadent has developed a patented innovative solution that enables safer and shorter restorative treatments:

- safer for dentists by reducing placement time (5x), thereby greatly improving ergonomics and minimizing the risk of operative errors

- safer for the patient with an increased material biocompatibilty and unparalleled resistance to the harsh oral environment

Funding: Noveadent is currently looking for funding to scale-up and move forward with industrialisation of its two medical devices.